ARCHIVES

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | March 14, 2008

Download PDF Visit The Full Archive

Related Articles

GAO Study Finds Lumpectomy Effective As Mastectomy In Trials And In Practice

November 25, 1994

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

In Brief: NBA, NCI Signs Agreement On Content OF PSAs; Broder Talks To NBA Wives; ASC Honors Frei

May 22, 1992

In Brief: Paul Van Nevel, Director Of NCI Communications, To Retire At Year’s End

November 26, 1999

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

“Dog And Pony Show” At FCRF For NCAB OFF

April 25, 1980